No products in the cart.
Return To ShopNo products in the cart.
Return To Shop€72.00
Cartel Labz SR-9009 Stenabolic is a synthetic compound designed to enhance athletic performance and promote fat loss. Often referred to as a Rev-ErbA agonist, this innovative substance aids in regulating metabolism and energy expenditure, making it a popular choice among athletes and bodybuilders. With a convenient 10mg dosage, Cartel Labz SR-9009 offers a potent way to elevate performance levels while reducing body fat percentage.
SR-9009 functions by binding to the Rev-ErbA protein, which plays a crucial role in the regulation of circadian rhythms and cellular metabolism. This interaction leads to increased mitochondrial biogenesis, enhancing energy production in muscle tissues. As a result, users may experience improved endurance, allowing for longer and more intense workouts. Additionally, SR-9009 has been shown to stimulate fat loss by altering how the body uses energy, promoting the breakdown of stored fat over carbohydrates. This dual action of increasing energy levels while facilitating fat usage makes SR-9009 particularly appealing for athletes looking to improve performance while maintaining lean muscle mass.
Purchasing Cartel Labz SR-9009 Stenabolic is a straightforward process, especially with the rise of online retailers specializing in sports supplements. The advantages of buying from a reputable store include the assurance of product quality and authenticity. Many online platforms offer detailed product information, customer reviews, and prompt shipping services to enhance your shopping experience. When looking to buy, always ensure you choose a vendor that provides transparent labeling and comprehensive product descriptions. Keep an eye out for promotions and bulk-buy options, as many stores offer discounts that could save you money in the long run.
While Cartel Labz SR-9009 Stenabolic has gained praise for its performance-enhancing effects, users should remain cautious about potential side effects. Commonly reported issues include headaches, insomnia, and mild gastrointestinal distress. It’s essential to adhere to recommended dosages and consult with a healthcare professional before beginning any new supplement regimen, particularly if you have pre-existing health conditions or are taking other medications. The long-term safety of SR-9009 has not been thoroughly studied, making it crucial for users to monitor their reactions and discontinue use if adverse effects occur.
Overall, Cartel Labz SR-9009 Stenabolic 10mg Cartel Labz presents numerous advantages for athletes looking to optimize their performance. Here’s a summary of the main benefits:
For athletes serious about maximizing their performance while minimizing fat, Cartel Labz SR-9009 Stenabolic is a valuable addition to their training arsenal.
| Water Retention | No significant water retention |
|---|---|
| Hepatotoxicity | Not enough data to determine |
| Lab Test | Specific tests for detection in blood or urine not widely detailed |
| Strength | 10 mg |
| Also known as | SR9009, Stenabolic |
| Blood pressure | No significant impact reported |
| Trade name | Not available under any trade name as it is not commercially marketed |
| Storage conditions | Store at room temperature away from moisture and light |
| Chemical name | Ethyl 3-[[(4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino]methyl]pyrrolidine-1-carboxylate |
| Formula | C20H24ClN3O4S |
| Substance class | Synthetic drug, Rev-ErbA ligand |
| Main action | Activates Rev-ErbA which increases mitochondrial count in muscle, decreases fat storage |
| Half-life | Approximately 4-5 hours |
| Dosage (medical) | Not clinically approved for medical use |
| Dosage (sports) | Typically 10-40 mg per day |
| Effects | Increased endurance, reduced fat mass, increased wakefulness |
| Side effects | Potential alterations in circadian rhythms, limited data on long-term effects |
| Use in sports | Used as a performance-enhancing drug, not approved by WADA |
| Manufacturer | Cartel Labz |
€138.00
Reviews
There are no reviews yet.